ANXA2 mean immunohistochemistry (IHC) score (intensity x staining percentage) was used to define high- and low-ANXA2 tumours and assess the correlation of ANXA2 expression with tumour’s clinical features. This evidence concerns the gene ANXA2 and neoplasm.